Patent risk management company RPX announced a deal to buy out the bulk of the assets owned by patent consortium Rockstar.» Read More
IBM and Pure Storage announced in a release that the private computer storage company has acquired more than 100 technology patents from IBM.
The U.S. Patent and Trademark Office has cancelled the Washington Redskins' trademark registration saying the name is "disparaging" to Native Americans.
Tesla CEO Elon Musk has announced it is opening up all its patents to competitors to spur innovation. CNBC's Phil LeBeau has the details.
CNBC's Phil LeBeau reports Tesla CEO Elon Musk has announced the automaker will open up its patents to spur innovation in the auto industry.
Patents help spur innovation and competitiveness in the U.S., says Joe Beyers, Inventergy chairman and CEO.
Joe Beyers, Inventergy chairman and CEO, shares the company's business model and reasons for going public.
Analysts say there's more to Merck's interest in Idenix than its drug portfolio: intellectual property. And that's why Gilead's shares are lower.
"What happened in electronics and software is about to happen in biology," says Jay Walker, Patent Properties chairman, discussing the impending explosion in the health and wellness sector. Walker also explains how Apple's "HealthKit" may be paving the way towards a market with tech driven, individualized health care.
CNBC's Meg Tirrell reports Sanofi and Eli Lilly announced an agreement to pursue regulatory approval of an over-the-counter version of erectile dysfunction drug Cialis.
Discussing hot picks in the biotech space, with Matthew Roden, UBS executive director.
The epic patent fight between Samsung and Apple ended on Monday after a jury ordered Samsung pay $120 million in damages for copying iPhone technology. Kurt Eichenwald, Vanity Fair, profiled the mobile giants in the June issue.
The Samsung-Apple litigation underscored the troubled U.S. patent system, and something worse, Priceline.com founder Jay Walker tells CNBC.
Priceline.com founder Jay Walker, discusses the patent war between Apple and Samsung and explains his new venture created to solve America's patent problem.
Hardeep Walia, co-founder and CEO of Motif Investing, shares his firm's findings on the most popular trends in investing right now, including high-yield dividends.
Apple is making some broad claims about what it owns and will have to make a strong case to prove it actually deserves as much as it is asking for.
CNBC's Jim Cramer speaks with Robert Hugin, Celgene chairman & CEO, about America's need to build a stronger and more sustainable ecosystem of innovation to continue as the world leader in biomedical innovation.
Richard Pops, chairman & CEO of Alkermes, discusses Alkermes' new injectable drug for the treatment of schizophrenia. We have more psychiatry products in our pipeline, reveals Pops.
John Lechleiter, Chairman, President & CEO of Eli Lilly, discusses the company's growth plans as products come off patent and consumers move to generic drugs.
Samsung began its opening argument on Tuesday, saying that Apple's patents aren't nearly as broad or important as the company claims.
CNBC's Jon Fortt and investor Kevin O'Leary of "Shark Tank," discusses Apple's patent infringement battle with Samsung.